神户大学研究人员查明了与特定自我瞄准抗体有关的经常怀孕损失妇女提高全时妊娠成功率的治疗方法。 Kobe University researchers identify treatment enhancing full-term pregnancy success in women with recurrent pregnancy loss linked to a specific self-targeting antibody.

神户大学的研究人员已经确定了一种治疗方法,可以加强与特定自我瞄准抗体有关的经常怀孕损失妇女的全面妊娠成功率。 Researchers from Kobe University have identified a treatment that enhances full-term pregnancy success in women with recurrent pregnancy loss linked to a specific self-targeting antibody. 该研究在免疫学前沿发表,发现接受低剂量阿司匹林或肝素的妇女的活产生育率为87%,而未经治疗的妇女为50%。 Published in Frontiers in Immunology, the study found that women receiving low-dose aspirin or heparin had an 87% live birth rate, compared to 50% for untreated women. 此外,治疗将妊娠并发症从50%减少到6%,表明有可能在相关条件下更广泛地应用。 Additionally, treatment reduced pregnancy complications from 50% to 6%, suggesting potential for broader applications in related conditions.